IMP
Process View
negative regulation of cysteine type endopeptidase activity involved in apoptotic process
Any process that stops, prevents, or reduces the frequency, rate or extent of a cysteine-type endopeptidase activity involved in the apoptotic process.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of cysteine type endopeptidase activity involved in apoptotic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide | 1.000 | Human | |
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 1.000 | ||
| YWHAG | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide | 0.998 | Human | |
| YWHAB | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide | 0.986 | Human | |
| FAS | Fas (TNF receptor superfamily, member 6) | 0.980 | ||
| CFLAR | CASP8 and FADD-like apoptosis regulator | 0.977 | Mouse | |
| XIAP | X-linked inhibitor of apoptosis | 0.954 | ||
| YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide | 0.948 | Human | |
| MAPK14 | mitogen-activated protein kinase 14 | 0.943 | ||
| EGFR | epidermal growth factor receptor | 0.931 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.931 | ||
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.924 | ||
| MAPK1 | mitogen-activated protein kinase 1 | 0.924 | ||
| FADD | Fas (TNFRSF6)-associated via death domain | 0.891 | ||
| GRB2 | growth factor receptor-bound protein 2 | 0.809 | ||
| GSK3B | glycogen synthase kinase 3 beta | 0.790 | ||
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.783 | ||
| RB1 | retinoblastoma 1 | 0.775 | ||
| TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.770 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.761 | ||
| BIRC2 | baculoviral IAP repeat containing 2 | 0.741 | Human | |
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.727 | ||
| TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.727 | ||
| DUSP1 | dual specificity phosphatase 1 | 0.688 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.673 | ||
| TNFRSF6B | tumor necrosis factor receptor superfamily, member 6b, decoy | 0.661 | ||
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.650 | ||
| WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.646 | ||
| BID | BH3 interacting domain death agonist | 0.645 | ||
| MAPK3 | mitogen-activated protein kinase 3 | 0.619 | ||
| LCK | lymphocyte-specific protein tyrosine kinase | 0.566 | Human | |
| PAK2 | p21 protein (Cdc42/Rac)-activated kinase 2 | 0.549 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.530 | ||
| HCK | hemopoietic cell kinase | 0.523 | Human | |
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.521 | ||
| BAD | BCL2-associated agonist of cell death | 0.503 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.470 | ||
| MAP2K1 | mitogen-activated protein kinase kinase 1 | 0.463 | ||
| SH3RF1 | SH3 domain containing ring finger 1 | 0.458 | ||
| VEGFA | vascular endothelial growth factor A | 0.442 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.433 | ||
| BCL2L1 | BCL2-like 1 | 0.432 | Zebrafish Rat | |
| TRAF1 | TNF receptor-associated factor 1 | 0.404 | ||
| PAFAH1B3 | platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 (29kDa) | 0.385 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.361 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.360 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.357 | ||
| RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.339 | ||
| TXN | thioredoxin | 0.322 | ||
| SPRR2A | small proline-rich protein 2A | 0.313 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.293 | ||
| BCL2 | B-cell CLL/lymphoma 2 | 0.292 | Zebrafish | |
| SOD1 | superoxide dismutase 1, soluble | 0.292 | ||
| ARHGEF7 | Rho guanine nucleotide exchange factor (GEF) 7 | 0.289 | ||
| PRDX1 | peroxiredoxin 1 | 0.287 | Human | |
| MAP3K3 | mitogen-activated protein kinase kinase kinase 3 | 0.263 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.263 | Human | |
| AXL | AXL receptor tyrosine kinase | 0.259 | ||
| PML | promyelocytic leukemia | 0.253 | ||
| CREBBP | CREB binding protein | 0.240 | ||
| PSEN1 | presenilin 1 | 0.237 | ||
| ARRB2 | arrestin, beta 2 | 0.236 | Rat | |
| EP300 | E1A binding protein p300 | 0.236 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.231 | Human | |
| MDM4 | Mdm4 p53 binding protein homolog (mouse) | 0.226 | ||
| MAPK8IP2 | mitogen-activated protein kinase 8 interacting protein 2 | 0.226 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.223 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.223 | ||
| KLF6 | Kruppel-like factor 6 | 0.211 | Human | |
| KPNA1 | karyopherin alpha 1 (importin alpha 5) | 0.209 | ||
| BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.208 | ||
| MAP3K2 | mitogen-activated protein kinase kinase kinase 2 | 0.207 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.206 | ||
| BLNK | B-cell linker | 0.199 | ||
| KLF4 | Kruppel-like factor 4 (gut) | 0.190 | ||
| BIRC3 | baculoviral IAP repeat containing 3 | 0.189 | Human | |
| MAPT | microtubule-associated protein tau | 0.185 | ||
| PCDHA4 | protocadherin alpha 4 | 0.179 | ||
| BAX | BCL2-associated X protein | 0.179 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.177 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.176 | ||
| BTRC | beta-transducin repeat containing | 0.165 | ||
| NRP1 | neuropilin 1 | 0.158 | ||
| DAXX | death-domain associated protein | 0.157 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.157 | ||
| PRDX4 | peroxiredoxin 4 | 0.155 | Human | |
| GBP2 | guanylate binding protein 2, interferon-inducible | 0.148 | ||
| PDPK1 | 3-phosphoinositide dependent protein kinase-1 | 0.148 | ||
| CDK6 | cyclin-dependent kinase 6 | 0.148 | ||
| JUN | jun proto-oncogene | 0.140 | ||
| UBC | ubiquitin C | 0.132 | ||
| ITK | IL2-inducible T-cell kinase | 0.131 | ||
| TTR | transthyretin | 0.128 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.127 | ||
| UBQLN1 | ubiquilin 1 | 0.125 | ||
| TP53BP2 | tumor protein p53 binding protein, 2 | 0.124 | ||
| HDAC6 | histone deacetylase 6 | 0.120 | ||
| LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.119 | ||
| DAD1 | defender against cell death 1 | 0.117 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.115 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.114 | ||
| CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.113 | ||
| INSR | insulin receptor | 0.112 | ||
| SRF | serum response factor (c-fos serum response element-binding transcription factor) | 0.111 | ||
| SKP1 | S-phase kinase-associated protein 1 | 0.111 | ||
| MEOX1 | mesenchyme homeobox 1 | 0.110 | ||
| SH3RF3 | SH3 domain containing ring finger 3 | 0.110 | Human | |
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.108 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.106 | ||
| IQGAP1 | IQ motif containing GTPase activating protein 1 | 0.100 | ||
| CCND3 | cyclin D3 | 0.099 | ||
| ANXA1 | annexin A1 | 0.099 | ||
| PRKCA | protein kinase C, alpha | 0.096 | ||
| SFN | stratifin | 0.095 | ||
| NKX2-1 | NK2 homeobox 1 | 0.094 | ||
| HDAC1 | histone deacetylase 1 | 0.094 | ||
| YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide | 0.092 | Human | |
| HIPK3 | homeodomain interacting protein kinase 3 | 0.092 | ||
| TBC1D17 | TBC1 domain family, member 17 | 0.090 | ||
| PACSIN3 | protein kinase C and casein kinase substrate in neurons 3 | 0.089 | ||
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.089 | ||
| HSPA8 | heat shock 70kDa protein 8 | 0.088 | ||
| ATF2 | activating transcription factor 2 | 0.085 | ||
| IBTK | inhibitor of Bruton agammaglobulinemia tyrosine kinase | 0.084 | ||
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.084 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.081 | ||
| CDCA8 | cell division cycle associated 8 | 0.080 | ||
| PPP2CA | protein phosphatase 2, catalytic subunit, alpha isozyme | 0.079 | ||
| CCND1 | cyclin D1 | 0.076 | ||
| XRCC6 | X-ray repair complementing defective repair in Chinese hamster cells 6 | 0.073 | ||
| GADD45A | growth arrest and DNA-damage-inducible, alpha | 0.073 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.073 | ||
| EEF2K | eukaryotic elongation factor-2 kinase | 0.072 | ||
| EIF4B | eukaryotic translation initiation factor 4B | 0.072 | ||
| LRRK2 | leucine-rich repeat kinase 2 | 0.071 | ||
| MSN | moesin | 0.070 | ||
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.069 | ||
| RUNX1 | runt-related transcription factor 1 | 0.067 | ||
| YWHAQ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide | 0.067 | Human | |
| PTEN | phosphatase and tensin homolog | 0.066 | ||
| PIK3R3 | phosphoinositide-3-kinase, regulatory subunit 3 (gamma) | 0.065 | ||
| CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.065 | ||
| PPP6C | protein phosphatase 6, catalytic subunit | 0.064 | ||
| PSTPIP1 | proline-serine-threonine phosphatase interacting protein 1 | 0.064 | ||
| CSNK2A1 | casein kinase 2, alpha 1 polypeptide | 0.062 | ||
| PDGFC | platelet derived growth factor C | 0.061 | ||
| BAG1 | BCL2-associated athanogene | 0.061 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.061 | ||
| PLAT | plasminogen activator, tissue | 0.060 | Human | |
| CDKN2B | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) | 0.060 | ||
| BCL2A1 | BCL2-related protein A1 | 0.060 | Mouse | |
| SMAD3 | SMAD family member 3 | 0.060 | ||
| CFL1 | cofilin 1 (non-muscle) | 0.060 | ||
| GAS7 | growth arrest-specific 7 | 0.059 | ||
| STAU1 | staufen, RNA binding protein, homolog 1 (Drosophila) | 0.057 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.057 | ||
| TP53 | tumor protein p53 | 0.057 | ||
| INCENP | inner centromere protein antigens 135/155kDa | 0.055 | ||
| PGF | placental growth factor | 0.053 | Human | |
| CTBP1 | C-terminal binding protein 1 | 0.053 | ||
| CD320 | CD320 molecule | 0.053 | ||
| TRAF3 | TNF receptor-associated factor 3 | 0.052 | ||
| FBXW11 | F-box and WD repeat domain containing 11 | 0.052 | ||
| ENG | endoglin | 0.052 | ||
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.052 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.051 | ||
| YY1 | YY1 transcription factor | 0.051 | ||
| TCF4 | transcription factor 4 | 0.051 | ||
| CTNNA1 | catenin (cadherin-associated protein), alpha 1, 102kDa | 0.051 | ||
| TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 | 0.050 | Human | |
| CDC25B | cell division cycle 25 homolog B (S. pombe) | 0.050 | ||
| PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 0.050 | ||
| ADAM15 | ADAM metallopeptidase domain 15 | 0.049 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.048 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.048 | ||
| GPX4 | glutathione peroxidase 4 (phospholipid hydroperoxidase) | 0.048 | ||
| SIRT1 | sirtuin 1 | 0.047 | ||
| RHOA | ras homolog gene family, member A | 0.047 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.047 | Human | |
| NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.047 | ||
| USP7 | ubiquitin specific peptidase 7 (herpes virus-associated) | 0.046 | ||
| C1orf93 | chromosome 1 open reading frame 93 | 0.045 | ||
| MAPK7 | mitogen-activated protein kinase 7 | 0.045 | ||
| DUSP3 | dual specificity phosphatase 3 | 0.045 | ||
| SAT1 | spermidine/spermine N1-acetyltransferase 1 | 0.045 | ||
| PRDX2 | peroxiredoxin 2 | 0.044 | Human | |
| FZD5 | frizzled homolog 5 (Drosophila) | 0.044 | ||
| AHR | aryl hydrocarbon receptor | 0.043 | ||
| PRKACA | protein kinase, cAMP-dependent, catalytic, alpha | 0.043 | ||
| CCL14 | chemokine (C-C motif) ligand 14 | 0.043 | ||
| PARK7 | Parkinson disease (autosomal recessive, early onset) 7 | 0.042 | ||
| ASRGL1 | asparaginase like 1 | 0.042 | ||
| ADAMTSL4 | ADAMTS-like 4 | 0.042 | ||
| COASY | CoA synthase | 0.042 | ||
| ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.041 | ||
| LAMTOR1 | late endosomal/lysosomal adaptor, MAPK and MTOR activator 1 | 0.041 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.041 | ||
| LDLR | low density lipoprotein receptor | 0.041 | ||
| NAMPT | nicotinamide phosphoribosyltransferase | 0.041 | ||
| DIABLO | diablo, IAP-binding mitochondrial protein | 0.041 | ||
| MARK2 | MAP/microtubule affinity-regulating kinase 2 | 0.040 | ||
| ARRB1 | arrestin, beta 1 | 0.040 | Mouse | |
| PARD6B | par-6 partitioning defective 6 homolog beta (C. elegans) | 0.040 | ||
| CHN2 | chimerin (chimaerin) 2 | 0.040 | ||
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.040 | Rat | |
| SORBS2 | sorbin and SH3 domain containing 2 | 0.039 | ||
| EIF2S2 | eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa | 0.039 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.039 | ||
| CYR61 | cysteine-rich, angiogenic inducer, 61 | 0.038 | ||
| IRS1 | insulin receptor substrate 1 | 0.038 | ||
| HSPA1B | heat shock 70kDa protein 1B | 0.038 | ||
| ATXN3 | ataxin 3 | 0.038 | ||
| AMBRA1 | autophagy/beclin-1 regulator 1 | 0.038 | ||
| DNAJB1 | DnaJ (Hsp40) homolog, subfamily B, member 1 | 0.037 | ||
| KCTD17 | potassium channel tetramerisation domain containing 17 | 0.037 | ||
| IRF1 | interferon regulatory factor 1 | 0.037 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.037 | ||
| VEGFC | vascular endothelial growth factor C | 0.037 | Human | |
| MAPK10 | mitogen-activated protein kinase 10 | 0.037 | ||
| EMP1 | epithelial membrane protein 1 | 0.036 | ||
| PPP4C | protein phosphatase 4, catalytic subunit | 0.036 | ||
| C4orf14 | chromosome 4 open reading frame 14 | 0.036 | ||
| ETS1 | v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) | 0.036 | ||
| APAF1 | apoptotic peptidase activating factor 1 | 0.035 | ||
| LIMK1 | LIM domain kinase 1 | 0.035 | ||
| TRADD | TNFRSF1A-associated via death domain | 0.035 | ||
| BBS1 | Bardet-Biedl syndrome 1 | 0.035 | ||
| SP1 | Sp1 transcription factor | 0.035 | ||
| C19orf46 | chromosome 19 open reading frame 46 | 0.034 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.034 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.034 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.034 | ||
| HSP90AB1 | heat shock protein 90kDa alpha (cytosolic), class B member 1 | 0.034 | ||
| FIS1 | fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae) | 0.034 | ||
| COX7A2L | cytochrome c oxidase subunit VIIa polypeptide 2 like | 0.033 | ||
| CD79B | CD79b molecule, immunoglobulin-associated beta | 0.033 | ||
| PTPRR | protein tyrosine phosphatase, receptor type, R | 0.033 | ||
| CASP7 | caspase 7, apoptosis-related cysteine peptidase | 0.033 | ||
| MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.033 | ||
| PPP1CA | protein phosphatase 1, catalytic subunit, alpha isozyme | 0.033 | ||
| NR3C1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.033 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.033 | ||
| SNCA | synuclein, alpha (non A4 component of amyloid precursor) | 0.033 | ||
| RICTOR | RPTOR independent companion of MTOR, complex 2 | 0.032 | ||
| GNAQ | guanine nucleotide binding protein (G protein), q polypeptide | 0.032 | ||
| HIC1 | hypermethylated in cancer 1 | 0.032 | ||
| ALOX5 | arachidonate 5-lipoxygenase | 0.032 | ||
| TMOD3 | tropomodulin 3 (ubiquitous) | 0.031 | ||
| PIK3R2 | phosphoinositide-3-kinase, regulatory subunit 2 (beta) | 0.031 | ||
| PEA15 | phosphoprotein enriched in astrocytes 15 | 0.031 | ||
| PRDX6 | peroxiredoxin 6 | 0.030 | ||
| OAZ1 | ornithine decarboxylase antizyme 1 | 0.030 | ||
| SNX33 | sorting nexin 33 | 0.030 | ||
| MBNL1 | muscleblind-like (Drosophila) | 0.030 | ||
| PEBP1 | phosphatidylethanolamine binding protein 1 | 0.030 | ||
| NCKAP1 | NCK-associated protein 1 | 0.030 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.030 | ||
| AURKB | aurora kinase B | 0.030 | ||
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.029 | Mouse | |
| RABIF | RAB interacting factor | 0.029 | ||
| SGK1 | serum/glucocorticoid regulated kinase 1 | 0.029 | ||
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.029 | ||
| IGFBP3 | insulin-like growth factor binding protein 3 | 0.029 | ||
| TGIF1 | TGFB-induced factor homeobox 1 | 0.029 | ||
| USP2 | ubiquitin specific peptidase 2 | 0.029 | ||
| WWTR1 | WW domain containing transcription regulator 1 | 0.029 | ||
| SNCAIP | synuclein, alpha interacting protein | 0.029 | ||
| HES1 | hairy and enhancer of split 1, (Drosophila) | 0.028 | ||
| DHX34 | DEAH (Asp-Glu-Ala-His) box polypeptide 34 | 0.028 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.027 | ||
| MLL | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila) | 0.027 | ||
| APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.027 | ||
| STC1 | stanniocalcin 1 | 0.027 | ||
| YAP1 | Yes-associated protein 1 | 0.027 | ||
| EZR | ezrin | 0.027 | ||
| BAIAP2 | BAI1-associated protein 2 | 0.027 | ||
| CLEC3B | C-type lectin domain family 3, member B | 0.027 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.027 | ||
| NOTCH1 | notch 1 | 0.027 | ||
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.027 | ||
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.027 | ||
| STAT5A | signal transducer and activator of transcription 5A | 0.027 | ||
| RYBP | RING1 and YY1 binding protein | 0.027 | ||
| TNC | tenascin C | 0.026 | ||
| JUP | junction plakoglobin | 0.026 | ||
| RGS2 | regulator of G-protein signaling 2, 24kDa | 0.026 | ||
| TXNDC5 | thioredoxin domain containing 5 (endoplasmic reticulum) | 0.026 | ||
| DUSP23 | dual specificity phosphatase 23 | 0.026 | ||
| C10orf116 | chromosome 10 open reading frame 116 | 0.025 | ||
| ZNF331 | zinc finger protein 331 | 0.025 | ||
| ZRANB1 | zinc finger, RAN-binding domain containing 1 | 0.025 | ||
| RHOB | ras homolog gene family, member B | 0.025 | ||
| SOCS1 | suppressor of cytokine signaling 1 | 0.025 | ||
| VDAC1 | voltage-dependent anion channel 1 | 0.025 | ||
| STAM | signal transducing adaptor molecule (SH3 domain and ITAM motif) 1 | 0.025 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.025 | ||
| BAG2 | BCL2-associated athanogene 2 | 0.025 | ||
| FGF2 | fibroblast growth factor 2 (basic) | 0.025 | ||
| PRKCZ | protein kinase C, zeta | 0.025 | ||
| UTY | ubiquitously transcribed tetratricopeptide repeat gene, Y-linked | 0.025 | ||
| USP9X | ubiquitin specific peptidase 9, X-linked | 0.024 | ||
| EIF1AY | eukaryotic translation initiation factor 1A, Y-linked | 0.024 | ||
| NRP2 | neuropilin 2 | 0.024 | ||
| BTK | Bruton agammaglobulinemia tyrosine kinase | 0.024 | Human | |
| NCK1 | NCK adaptor protein 1 | 0.024 | ||
| CAPN1 | calpain 1, (mu/I) large subunit | 0.024 | ||
| ING1 | inhibitor of growth family, member 1 | 0.024 | ||
| EIF3C | eukaryotic translation initiation factor 3, subunit C | 0.024 | ||
| NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.024 | ||
| RNF19A | ring finger protein 19A | 0.024 | ||
| AMY2A | amylase, alpha 2A (pancreatic) | 0.024 | ||
| EBP | emopamil binding protein (sterol isomerase) | 0.024 | ||
| ZFP36L1 | zinc finger protein 36, C3H type-like 1 | 0.024 | ||
| NECAB2 | N-terminal EF-hand calcium binding protein 2 | 0.024 | ||
| EIF3F | eukaryotic translation initiation factor 3, subunit F | 0.024 | ||
| BCL2L2 | BCL2-like 2 | 0.023 | ||
| DAPK1 | death-associated protein kinase 1 | 0.023 | ||
| MASP1 | mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | 0.023 | ||
| RUNX3 | runt-related transcription factor 3 | 0.023 | ||
| HDAC11 | histone deacetylase 11 | 0.023 | ||
| KDM5D | lysine (K)-specific demethylase 5D | 0.023 | ||
| ORM1 | orosomucoid 1 | 0.023 | ||
| LMO4 | LIM domain only 4 | 0.023 | ||
| DHCR7 | 7-dehydrocholesterol reductase | 0.023 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.023 | ||
| DUSP6 | dual specificity phosphatase 6 | 0.023 | ||
| IL8 | interleukin 8 | 0.023 | ||
| PLEK | pleckstrin | 0.023 | ||
| AXIN1 | axin 1 | 0.023 | ||
| STK17A | serine/threonine kinase 17a | 0.023 | ||
| TENC1 | tensin like C1 domain containing phosphatase (tensin 2) | 0.023 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.022 | ||
| JAG1 | jagged 1 | 0.022 | ||
| DYNLL1 | dynein, light chain, LC8-type 1 | 0.022 | ||
| SORBS3 | sorbin and SH3 domain containing 3 | 0.022 | ||
| DUSP7 | dual specificity phosphatase 7 | 0.022 | ||
| PIM1 | pim-1 oncogene | 0.022 | ||
| ANGPTL2 | angiopoietin-like 2 | 0.022 | ||
| SLC1A2 | solute carrier family 1 (glial high affinity glutamate transporter), member 2 | 0.022 | ||
| MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.022 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.022 | ||
| CASP1 | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 0.022 | ||
| TK1 | thymidine kinase 1, soluble | 0.022 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.022 | ||
| SOD2 | superoxide dismutase 2, mitochondrial | 0.022 | ||
| CDKN2C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) | 0.022 | Human | |
| RIOK3 | RIO kinase 3 (yeast) | 0.021 | ||
| NUMB | numb homolog (Drosophila) | 0.021 | ||
| PTPN7 | protein tyrosine phosphatase, non-receptor type 7 | 0.021 | ||
| WIPF1 | WAS/WASL interacting protein family, member 1 | 0.021 | ||
| GNMT | glycine N-methyltransferase | 0.021 | ||
| KRAS | v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog | 0.021 | ||
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.021 | Human | |
| TNFRSF14 | tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) | 0.021 | ||
| DBI | diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) | 0.021 | ||
| OSMR | oncostatin M receptor | 0.021 | ||
| TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) | 0.021 | Human | |
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.021 | Zebrafish | |
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.021 | ||
| CSNK1E | casein kinase 1, epsilon | 0.021 | ||
| PRKCE | protein kinase C, epsilon | 0.021 | ||
| MAP3K14 | mitogen-activated protein kinase kinase kinase 14 | 0.020 | ||
| PPP2R2A | protein phosphatase 2, regulatory subunit B, alpha | 0.020 | ||
| NRIP1 | nuclear receptor interacting protein 1 | 0.020 | ||
| ARHGAP15 | Rho GTPase activating protein 15 | 0.020 | ||
| APP | amyloid beta (A4) precursor protein | 0.020 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.020 | ||
| POU2AF1 | POU class 2 associating factor 1 | 0.020 | ||
| CDKN2D | cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) | 0.020 | ||
| TBXA2R | thromboxane A2 receptor | 0.020 | ||
| MEX3C | mex-3 homolog C (C. elegans) | 0.020 | ||
| SBF1 | SET binding factor 1 | 0.020 | ||
| IFI27 | interferon, alpha-inducible protein 27 | 0.020 | Human | |
| COL1A1 | collagen, type I, alpha 1 | 0.020 | ||
| IQGAP2 | IQ motif containing GTPase activating protein 2 | 0.020 | ||
| PDIA6 | protein disulfide isomerase family A, member 6 | 0.020 | ||
| ZFAND5 | zinc finger, AN1-type domain 5 | 0.020 | ||
| MARK1 | MAP/microtubule affinity-regulating kinase 1 | 0.020 | ||
| VCAN | versican | 0.020 | ||
| CORO1B | coronin, actin binding protein, 1B | 0.020 | ||
| SERPINB2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | 0.020 | ||
| SLC7A11 | solute carrier family 7, (cationic amino acid transporter, y+ system) member 11 | 0.020 | ||
| NRG1 | neuregulin 1 | 0.019 | ||
| THBS2 | thrombospondin 2 | 0.019 | Human | |
| SETD7 | SET domain containing (lysine methyltransferase) 7 | 0.019 | ||
| ETNK2 | ethanolamine kinase 2 | 0.019 | ||
| E2F2 | E2F transcription factor 2 | 0.019 | ||
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.019 | ||
| BBS10 | Bardet-Biedl syndrome 10 | 0.019 | ||
| AKT1S1 | AKT1 substrate 1 (proline-rich) | 0.019 | ||
| CCR7 | chemokine (C-C motif) receptor 7 | 0.019 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.019 | Human | |
| GADD45B | growth arrest and DNA-damage-inducible, beta | 0.019 | ||
| CSF3R | colony stimulating factor 3 receptor (granulocyte) | 0.019 | ||
| CASP8AP2 | caspase 8 associated protein 2 | 0.019 | ||
| ALDOB | aldolase B, fructose-bisphosphate | 0.019 | ||
| TCOF1 | Treacher Collins-Franceschetti syndrome 1 | 0.019 | ||
| RPS6KA1 | ribosomal protein S6 kinase, 90kDa, polypeptide 1 | 0.019 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.019 | ||
| USP9Y | ubiquitin specific peptidase 9, Y-linked | 0.018 | ||
| ZNHIT1 | zinc finger, HIT-type containing 1 | 0.018 | ||
| RIPK4 | receptor-interacting serine-threonine kinase 4 | 0.018 | ||
| TANK | TRAF family member-associated NFKB activator | 0.018 | ||
| CD79A | CD79a molecule, immunoglobulin-associated alpha | 0.018 | ||
| GAS6 | growth arrest-specific 6 | 0.018 | ||
| KRT18 | keratin 18 | 0.018 | ||
| MAP2K4 | mitogen-activated protein kinase kinase 4 | 0.018 | ||
| ZNF267 | zinc finger protein 267 | 0.018 | ||
| MARCH5 | membrane-associated ring finger (C3HC4) 5 | 0.018 | ||
| BCL10 | B-cell CLL/lymphoma 10 | 0.018 | ||
| LAMTOR2 | late endosomal/lysosomal adaptor, MAPK and MTOR activator 2 | 0.018 | ||
| TAB1 | TGF-beta activated kinase 1/MAP3K7 binding protein 1 | 0.018 | ||
| STK17B | serine/threonine kinase 17b | 0.018 | ||
| MYC | v-myc myelocytomatosis viral oncogene homolog (avian) | 0.018 | ||
| BAK1 | BCL2-antagonist/killer 1 | 0.018 | ||
| FES | feline sarcoma oncogene | 0.018 | ||
| LRRC32 | leucine rich repeat containing 32 | 0.018 | ||
| UBE2B | ubiquitin-conjugating enzyme E2B (RAD6 homolog) | 0.017 | ||
| CTNNBIP1 | catenin, beta interacting protein 1 | 0.017 | ||
| SERPINB9 | serpin peptidase inhibitor, clade B (ovalbumin), member 9 | 0.017 | ||
| WBP4 | WW domain binding protein 4 (formin binding protein 21) | 0.017 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.017 | ||
| RHOJ | ras homolog gene family, member J | 0.017 | ||
| ATF3 | activating transcription factor 3 | 0.017 | ||
| CDC34 | cell division cycle 34 homolog (S. cerevisiae) | 0.017 | ||
| BRAF | v-raf murine sarcoma viral oncogene homolog B1 | 0.017 | ||
| TRAF2 | TNF receptor-associated factor 2 | 0.017 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.017 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.017 | ||
| FBXO33 | F-box protein 33 | 0.017 | ||
| CTGF | connective tissue growth factor | 0.017 | ||
| PDK1 | pyruvate dehydrogenase kinase, isozyme 1 | 0.017 | ||
| FNBP1 | formin binding protein 1 | 0.017 | ||
| VTN | vitronectin | 0.017 | ||
| FAIM3 | Fas apoptotic inhibitory molecule 3 | 0.017 | ||
| TOPORS | topoisomerase I binding, arginine/serine-rich, E3 ubiquitin protein ligase | 0.017 | ||
| PRDX3 | peroxiredoxin 3 | 0.017 | ||
| VASP | vasodilator-stimulated phosphoprotein | 0.017 | ||
| PGRMC1 | progesterone receptor membrane component 1 | 0.017 | ||
| PDCD6IP | programmed cell death 6 interacting protein | 0.017 | ||
| DUSP5 | dual specificity phosphatase 5 | 0.017 | ||
| FAM107A | family with sequence similarity 107, member A | 0.017 | ||
| INHBA | inhibin, beta A | 0.017 | ||
| PTX3 | pentraxin 3, long | 0.017 | ||
| EFEMP2 | EGF containing fibulin-like extracellular matrix protein 2 | 0.017 | ||
| PEBP4 | phosphatidylethanolamine-binding protein 4 | 0.017 | ||
| CAMKK1 | calcium/calmodulin-dependent protein kinase kinase 1, alpha | 0.017 | ||
| RAB27A | RAB27A, member RAS oncogene family | 0.017 | ||
| EDN1 | endothelin 1 | 0.017 | ||
| TFR2 | transferrin receptor 2 | 0.017 | ||
| TSC22D3 | TSC22 domain family, member 3 | 0.017 | ||
| SRPX | sushi-repeat containing protein, X-linked | 0.017 | ||
| ADAMTS2 | ADAM metallopeptidase with thrombospondin type 1 motif, 2 | 0.016 | ||
| CHCHD4 | coiled-coil-helix-coiled-coil-helix domain containing 4 | 0.016 | ||
| NLRP1 | NLR family, pyrin domain containing 1 | 0.016 | ||
| AR | androgen receptor | 0.016 | ||
| CUX1 | cut-like homeobox 1 | 0.016 | ||
| NCF1 | neutrophil cytosolic factor 1 | 0.016 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.016 | Mouse | |
| THBD | thrombomodulin | 0.016 | ||
| UBE3A | ubiquitin protein ligase E3A | 0.016 | ||
| S1PR1 | sphingosine-1-phosphate receptor 1 | 0.016 | ||
| TSC2 | tuberous sclerosis 2 | 0.016 | ||
| HSBP1 | heat shock factor binding protein 1 | 0.016 | ||
| GAS2L3 | growth arrest-specific 2 like 3 | 0.016 | ||
| ARHGDIA | Rho GDP dissociation inhibitor (GDI) alpha | 0.016 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.016 | ||
| IRS2 | insulin receptor substrate 2 | 0.016 | ||
| GREM1 | gremlin 1 | 0.016 | ||
| THBS1 | thrombospondin 1 | 0.016 | ||
| TRAP1 | TNF receptor-associated protein 1 | 0.016 | ||
| NEDD8 | neural precursor cell expressed, developmentally down-regulated 8 | 0.016 | ||
| TLN1 | talin 1 | 0.016 | ||
| CDK11B | cyclin-dependent kinase 11B | 0.016 | ||
| EHMT2 | euchromatic histone-lysine N-methyltransferase 2 | 0.016 | ||
| ARID3A | AT rich interactive domain 3A (BRIGHT-like) | 0.016 | ||
| UBASH3B | ubiquitin associated and SH3 domain containing B | 0.016 | ||
| LGALS3BP | lectin, galactoside-binding, soluble, 3 binding protein | 0.016 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.016 | ||
| DCN | decorin | 0.016 | ||
| ISG20 | interferon stimulated exonuclease gene 20kDa | 0.016 | ||
| CAV2 | caveolin 2 | 0.016 | ||
| E2F1 | E2F transcription factor 1 | 0.016 | ||
| FDFT1 | farnesyl-diphosphate farnesyltransferase 1 | 0.016 | ||
| SQSTM1 | sequestosome 1 | 0.015 | ||
| BRMS1 | breast cancer metastasis suppressor 1 | 0.015 | ||
| RGS14 | regulator of G-protein signaling 14 | 0.015 | ||
| KLF10 | Kruppel-like factor 10 | 0.015 | ||
| TNF | tumor necrosis factor | 0.015 | ||
| CHRNA4 | cholinergic receptor, nicotinic, alpha 4 | 0.015 | ||
| KNG1 | kininogen 1 | 0.015 | ||
| CASP4 | caspase 4, apoptosis-related cysteine peptidase | 0.015 | ||
| PPP2R1A | protein phosphatase 2, regulatory subunit A, alpha | 0.015 | ||
| ROBO2 | roundabout, axon guidance receptor, homolog 2 (Drosophila) | 0.015 | ||
| DUSP9 | dual specificity phosphatase 9 | 0.015 | ||
| FLT4 | fms-related tyrosine kinase 4 | 0.015 | ||
| IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.015 | ||
| LOXL2 | lysyl oxidase-like 2 | 0.015 | ||
| WEE1 | WEE1 homolog (S. pombe) | 0.015 | ||
| C7orf59 | chromosome 7 open reading frame 59 | 0.015 | ||
| C13orf15 | chromosome 13 open reading frame 15 | 0.015 | ||
| LEPR | leptin receptor | 0.015 | ||
| BGN | biglycan | 0.015 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.015 | ||
| CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | 0.015 | ||
| SRGN | serglycin | 0.015 | ||
| GSN | gelsolin | 0.015 | ||
| BCL11A | B-cell CLL/lymphoma 11A (zinc finger protein) | 0.015 | ||
| CSNK2A2 | casein kinase 2, alpha prime polypeptide | 0.015 | Human | |
| PACSIN1 | protein kinase C and casein kinase substrate in neurons 1 | 0.015 | ||
| RIPK3 | receptor-interacting serine-threonine kinase 3 | 0.015 | ||
| ACTG1 | actin, gamma 1 | 0.015 | ||
| SH3BP5 | SH3-domain binding protein 5 (BTK-associated) | 0.015 | ||
| GCGR | glucagon receptor | 0.015 | ||
| SIAH2 | seven in absentia homolog 2 (Drosophila) | 0.015 | ||
| ARHGAP9 | Rho GTPase activating protein 9 | 0.015 | ||
| APOM | apolipoprotein M | 0.015 | ||
| HAS2 | hyaluronan synthase 2 | 0.015 | ||
| HNF1A | HNF1 homeobox A | 0.015 | ||
| GBP1 | guanylate binding protein 1, interferon-inducible | 0.015 | ||
| USP15 | ubiquitin specific peptidase 15 | 0.015 | ||
| PSEN2 | presenilin 2 (Alzheimer disease 4) | 0.015 | ||
| RPS6KA2 | ribosomal protein S6 kinase, 90kDa, polypeptide 2 | 0.015 | Human | |
| PLG | plasminogen | 0.014 | Human | |
| ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.014 | ||
| ERN1 | endoplasmic reticulum to nucleus signaling 1 | 0.014 | ||
| TNIK | TRAF2 and NCK interacting kinase | 0.014 | ||
| IL18RAP | interleukin 18 receptor accessory protein | 0.014 | ||
| CDKN1B | cyclin-dependent kinase inhibitor 1B (p27, Kip1) | 0.014 | ||
| TM4SF1 | transmembrane 4 L six family member 1 | 0.014 | ||
| CRYAB | crystallin, alpha B | 0.014 | ||
| TFCP2 | transcription factor CP2 | 0.014 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.014 | ||
| LRP1 | low density lipoprotein receptor-related protein 1 | 0.014 | ||
| CALM1 | calmodulin 1 (phosphorylase kinase, delta) | 0.014 | ||
| FGF7 | fibroblast growth factor 7 | 0.014 | ||
| CD58 | CD58 molecule | 0.014 | ||
| RANBP9 | RAN binding protein 9 | 0.014 | ||
| PER1 | period homolog 1 (Drosophila) | 0.014 | ||
| HBEGF | heparin-binding EGF-like growth factor | 0.014 | ||
| LBX1 | ladybird homeobox 1 | 0.014 | ||
| HIST2H2AB | histone cluster 2, H2ab | 0.014 | ||
| RING1 | ring finger protein 1 | 0.014 | ||
| FOSL2 | FOS-like antigen 2 | 0.014 | ||
| KIAA1377 | KIAA1377 | 0.014 | ||
| DCTN1 | dynactin 1 | 0.014 | ||
| SMAD4 | SMAD family member 4 | 0.014 | ||
| GOT2 | glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2) | 0.014 | ||
| PECAM1 | platelet/endothelial cell adhesion molecule | 0.014 | ||
| PRDX5 | peroxiredoxin 5 | 0.014 | ||
| PTAFR | platelet-activating factor receptor | 0.014 | ||
| ZFY | zinc finger protein, Y-linked | 0.014 | ||
| ETS2 | v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) | 0.014 | ||
| DLG4 | discs, large homolog 4 (Drosophila) | 0.014 | ||
| SH3PXD2A | SH3 and PX domains 2A | 0.014 | ||
| THY1 | Thy-1 cell surface antigen | 0.014 | ||
| CDH16 | cadherin 16, KSP-cadherin | 0.014 | ||
| PLXDC1 | plexin domain containing 1 | 0.014 | ||
| ABCG8 | ATP-binding cassette, sub-family G (WHITE), member 8 | 0.013 | ||
| JAG2 | jagged 2 | 0.013 | ||
| MAP3K1 | mitogen-activated protein kinase kinase kinase 1 | 0.013 | ||
| NACAD | NAC alpha domain containing | 0.013 | ||
| SERPINF2 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 | 0.013 | ||
| INHBB | inhibin, beta B | 0.013 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.013 | ||
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.013 | ||
| CYP51A1 | cytochrome P450, family 51, subfamily A, polypeptide 1 | 0.013 | ||
| MBP | myelin basic protein | 0.013 | ||
| APC | adenomatous polyposis coli | 0.013 | ||
| SMAD1 | SMAD family member 1 | 0.013 | ||
| NSDHL | NAD(P) dependent steroid dehydrogenase-like | 0.013 | ||
| SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 0.013 | ||
| ZC3HC1 | zinc finger, C3HC-type containing 1 | 0.013 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.013 | ||
| NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 | 0.013 | ||
| TNFSF11 | tumor necrosis factor (ligand) superfamily, member 11 | 0.013 | Human | |
| UBL5 | ubiquitin-like 5 | 0.013 | ||
| HDAC4 | histone deacetylase 4 | 0.013 | ||
| PLD1 | phospholipase D1, phosphatidylcholine-specific | 0.013 | ||
| PPP2R5C | protein phosphatase 2, regulatory subunit B', gamma | 0.013 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.013 | ||
| KLF2 | Kruppel-like factor 2 (lung) | 0.013 | Human | |
| ISG15 | ISG15 ubiquitin-like modifier | 0.013 | ||
| SMAD6 | SMAD family member 6 | 0.013 | ||
| HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.013 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.013 | ||
| LAMB2 | laminin, beta 2 (laminin S) | 0.013 | ||
| AMT | aminomethyltransferase | 0.013 | ||
| ARF6 | ADP-ribosylation factor 6 | 0.013 | ||
| SMEK1 | SMEK homolog 1, suppressor of mek1 (Dictyostelium) | 0.013 | ||
| TFPI2 | tissue factor pathway inhibitor 2 | 0.013 | ||
| MMP7 | matrix metallopeptidase 7 (matrilysin, uterine) | 0.013 | ||
| ZNRF1 | zinc and ring finger 1 | 0.013 | ||
| GNAS | GNAS complex locus | 0.013 | ||
| MYOF | myoferlin | 0.013 | ||
| LSM1 | LSM1 homolog, U6 small nuclear RNA associated (S. cerevisiae) | 0.013 | ||
| LSS | lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) | 0.013 | ||
| MN1 | meningioma (disrupted in balanced translocation) 1 | 0.013 | ||
| HSPH1 | heat shock 105kDa/110kDa protein 1 | 0.013 | ||
| SLIT2 | slit homolog 2 (Drosophila) | 0.013 | ||
| BCAP31 | B-cell receptor-associated protein 31 | 0.013 | ||
| TCF7 | transcription factor 7 (T-cell specific, HMG-box) | 0.013 | Human | |
| UBXN1 | UBX domain protein 1 | 0.013 | ||
| RASGRP2 | RAS guanyl releasing protein 2 (calcium and DAG-regulated) | 0.013 | ||
| PRRX1 | paired related homeobox 1 | 0.013 | ||
| PTGER4 | prostaglandin E receptor 4 (subtype EP4) | 0.013 | ||
| NMI | N-myc (and STAT) interactor | 0.013 | ||
| CPN1 | carboxypeptidase N, polypeptide 1 | 0.013 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.013 | ||
| SLC6A4 | solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 | 0.013 | ||
| CAMLG | calcium modulating ligand | 0.013 | ||
| LEF1 | lymphoid enhancer-binding factor 1 | 0.013 | ||
| CDH2 | cadherin 2, type 1, N-cadherin (neuronal) | 0.013 | ||
| GLIS2 | GLIS family zinc finger 2 | 0.013 | ||
| NOTCH3 | notch 3 | 0.012 | ||
| PSMD11 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 11 | 0.012 | ||
| BTG1 | B-cell translocation gene 1, anti-proliferative | 0.012 | ||
| PURB | purine-rich element binding protein B | 0.012 | ||
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.012 | ||
| NOL3 | nucleolar protein 3 (apoptosis repressor with CARD domain) | 0.012 | Rat | |
| SLCO2A1 | solute carrier organic anion transporter family, member 2A1 | 0.012 | ||
| BAG3 | BCL2-associated athanogene 3 | 0.012 | ||
| SPTBN4 | spectrin, beta, non-erythrocytic 4 | 0.012 | ||
| CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.012 | ||
| STAT2 | signal transducer and activator of transcription 2, 113kDa | 0.012 | ||
| SEMA6A | sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A | 0.012 | ||
| HSPA1A | heat shock 70kDa protein 1A | 0.012 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.012 | ||
| SIRT6 | sirtuin 6 | 0.012 | ||
| EI24 | etoposide induced 2.4 mRNA | 0.012 | ||
| TGFA | transforming growth factor, alpha | 0.012 | ||
| CA4 | carbonic anhydrase IV | 0.012 | ||
| EMD | emerin | 0.012 | ||
| F3 | coagulation factor III (thromboplastin, tissue factor) | 0.012 | ||
| NEDD4L | neural precursor cell expressed, developmentally down-regulated 4-like | 0.012 | ||
| SMAD7 | SMAD family member 7 | 0.012 | ||
| CCDC6 | coiled-coil domain containing 6 | 0.012 | ||
| APOB | apolipoprotein B (including Ag(x) antigen) | 0.012 | ||
| FKBP8 | FK506 binding protein 8, 38kDa | 0.012 | ||
| CSDA | cold shock domain protein A | 0.012 | ||
| BMP4 | bone morphogenetic protein 4 | 0.012 | ||
| SLC2A4RG | SLC2A4 regulator | 0.012 | ||
| IL7R | interleukin 7 receptor | 0.012 | ||
| PPM1D | protein phosphatase, Mg2+/Mn2+ dependent, 1D | 0.012 | ||
| C5AR1 | complement component 5a receptor 1 | 0.012 | ||
| PARD6G | par-6 partitioning defective 6 homolog gamma (C. elegans) | 0.012 | ||
| GADD45G | growth arrest and DNA-damage-inducible, gamma | 0.012 | ||
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.012 | ||
| CD6 | CD6 molecule | 0.012 | ||
| FPR1 | formyl peptide receptor 1 | 0.012 | ||
| FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) | 0.012 | ||
| TRIM21 | tripartite motif containing 21 | 0.012 | ||
| TNFRSF25 | tumor necrosis factor receptor superfamily, member 25 | 0.012 | ||
| FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.012 | Human | |
| WISP1 | WNT1 inducible signaling pathway protein 1 | 0.012 | ||
| HK2 | hexokinase 2 | 0.012 | ||
| STAP2 | signal transducing adaptor family member 2 | 0.012 | ||
| CIITA | class II, major histocompatibility complex, transactivator | 0.012 | ||
| MITF | microphthalmia-associated transcription factor | 0.012 | ||
| WISP2 | WNT1 inducible signaling pathway protein 2 | 0.012 | ||
| BIK | BCL2-interacting killer (apoptosis-inducing) | 0.012 | ||
| TGFBI | transforming growth factor, beta-induced, 68kDa | 0.012 | ||
| KLF9 | Kruppel-like factor 9 | 0.012 | ||
| BBC3 | BCL2 binding component 3 | 0.012 | ||
| ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.012 | ||
| HOXB7 | homeobox B7 | 0.012 | ||
| RAMP3 | receptor (G protein-coupled) activity modifying protein 3 | 0.012 | ||
| MRC2 | mannose receptor, C type 2 | 0.012 | ||
| RPS27L | ribosomal protein S27-like | 0.012 | ||
| IRF9 | interferon regulatory factor 9 | 0.012 | ||
| SCD | stearoyl-CoA desaturase (delta-9-desaturase) | 0.012 | ||
| SLA | Src-like-adaptor | 0.012 | ||
| CCT4 | chaperonin containing TCP1, subunit 4 (delta) | 0.012 | ||
| KYNU | kynureninase | 0.012 | ||
| GEM | GTP binding protein overexpressed in skeletal muscle | 0.012 | ||
| PPP3R1 | protein phosphatase 3, regulatory subunit B, alpha | 0.012 | ||
| ADAM19 | ADAM metallopeptidase domain 19 | 0.012 | ||
| TRIM39 | tripartite motif containing 39 | 0.012 | ||
| NFATC4 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 | 0.012 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.012 | ||
| GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.012 | ||
| ATP6V1E1 | ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1 | 0.012 | ||
| TSPO | translocator protein (18kDa) | 0.012 | ||
| SLURP1 | secreted LY6/PLAUR domain containing 1 | 0.012 | ||
| TFPI | tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) | 0.012 | ||
| ABI3 | ABI family, member 3 | 0.012 | ||
| IFI44L | interferon-induced protein 44-like | 0.012 | ||
| MDFI | MyoD family inhibitor | 0.012 | ||
| RSAD2 | radical S-adenosyl methionine domain containing 2 | 0.011 | ||
| MT1A | metallothionein 1A | 0.011 | ||
| PDCD6 | programmed cell death 6 | 0.011 | ||
| POFUT1 | protein O-fucosyltransferase 1 | 0.011 | ||
| CDC42EP3 | CDC42 effector protein (Rho GTPase binding) 3 | 0.011 | ||
| ADRBK1 | adrenergic, beta, receptor kinase 1 | 0.011 | ||
| RIN2 | Ras and Rab interactor 2 | 0.011 | ||
| BRP44 | brain protein 44 | 0.011 | ||
| FNDC3B | fibronectin type III domain containing 3B | 0.011 | ||
| GRK6 | G protein-coupled receptor kinase 6 | 0.011 | ||
| PDCD1 | programmed cell death 1 | 0.011 | ||
| HTRA3 | HtrA serine peptidase 3 | 0.011 | ||
| DNTT | deoxynucleotidyltransferase, terminal | 0.011 | ||
| COL6A3 | collagen, type VI, alpha 3 | 0.011 | ||
| FGF3 | fibroblast growth factor 3 | 0.011 | ||
| S100A10 | S100 calcium binding protein A10 | 0.011 | ||
| MAT2A | methionine adenosyltransferase II, alpha | 0.011 | ||
| ADAMTS5 | ADAM metallopeptidase with thrombospondin type 1 motif, 5 | 0.011 | ||
| LTB | lymphotoxin beta (TNF superfamily, member 3) | 0.011 | ||
| ARHGEF6 | Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 | 0.011 | ||
| TRAF5 | TNF receptor-associated factor 5 | 0.011 | ||
| TPPP | tubulin polymerization promoting protein | 0.011 | ||
| TNFSF8 | tumor necrosis factor (ligand) superfamily, member 8 | 0.011 | ||
| CHFR | checkpoint with forkhead and ring finger domains | 0.011 | ||
| TNS4 | tensin 4 | 0.011 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.011 | ||
| ECM1 | extracellular matrix protein 1 | 0.011 | ||
| PPP2R1B | protein phosphatase 2, regulatory subunit A, beta | 0.011 | ||
| TTLL12 | tubulin tyrosine ligase-like family, member 12 | 0.011 | ||
| OBFC2A | oligonucleotide/oligosaccharide-binding fold containing 2A | 0.011 | ||
| TNFRSF11B | tumor necrosis factor receptor superfamily, member 11b | 0.011 | ||
| BTBD2 | BTB (POZ) domain containing 2 | 0.011 | ||
| OLR1 | oxidized low density lipoprotein (lectin-like) receptor 1 | 0.011 | ||
| AKAP12 | A kinase (PRKA) anchor protein 12 | 0.011 | ||
| KLF3 | Kruppel-like factor 3 (basic) | 0.011 | Human | |
| ADORA1 | adenosine A1 receptor | 0.011 | ||
| ELK1 | ELK1, member of ETS oncogene family | 0.011 | ||
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.011 | ||
| IL15 | interleukin 15 | 0.011 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.011 | ||
| CYP1B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 | 0.011 | ||
| VSX1 | visual system homeobox 1 | 0.011 | ||
| POLH | polymerase (DNA directed), eta | 0.011 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.011 | ||
| MUL1 | mitochondrial E3 ubiquitin protein ligase 1 | 0.011 | ||
| TCEB2 | transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B) | 0.011 | ||
| SLIT3 | slit homolog 3 (Drosophila) | 0.011 | ||
| SPTA1 | spectrin, alpha, erythrocytic 1 (elliptocytosis 2) | 0.011 | ||
| CBX4 | chromobox homolog 4 | 0.011 | ||
| SFRP2 | secreted frizzled-related protein 2 | 0.011 | Mouse | |
| RIC8A | resistance to inhibitors of cholinesterase 8 homolog A (C. elegans) | 0.011 | ||
| PRMT6 | protein arginine methyltransferase 6 | 0.011 | ||
| ATXN7 | ataxin 7 | 0.011 | ||
| ZFX | zinc finger protein, X-linked | 0.011 | ||
| NR2F2 | nuclear receptor subfamily 2, group F, member 2 | 0.011 | ||
| BABAM1 | BRISC and BRCA1 A complex member 1 | 0.011 | ||
| SLC4A1 | solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group) | 0.011 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.011 | ||
| NOP10 | NOP10 ribonucleoprotein homolog (yeast) | 0.011 | ||
| LIPC | lipase, hepatic | 0.011 | ||
| KLF5 | Kruppel-like factor 5 (intestinal) | 0.011 | Human | |
| PCGF2 | polycomb group ring finger 2 | 0.011 |